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Abstract
Schizophrenia is a complex disorder caused by both genetic and environmental factors. Using
9,087 cases, 12,171 controls and 915,354 imputed SNPs from the Psychiatric GWA Consortium
for schizophrenia (PGC-SCZ) we estimate that 23% (s.e. 1%) of variation in liability to
schizophrenia is captured by SNPs. We show that an important proportion of this variation must
be due to common causal variants, that the variance explained by each chromosome is linearly
related to its length (r = 0.89, p = 2.6 × 10−8), that the genetic basis of schizophrenia is the same in
males and females, and that a disproportionate proportion of variation is attributable to a set of
2725 genes expressed in the central nervous system (CNS) (p = 7.6 ×10−8). These results are
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consistent with a polygenic genetic architecture and imply more individual SNP associations will
be detected for this disease as sample size increases.
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Schizophrenia is a severe mental disorder with lifetime risk ~1% and heritability of ~0.7 to
0.81–3. Of all complex genetic diseases, the genetic architecture of schizophrenia perhaps
has received the most speculation and debate4,5 and the relative importance of common
causal variants remains controversial6,7. Genome-wide association (GWA) studies of
schizophrenia have discovered associated variants8–10 that together explain only a small
fraction of the heritability11. Here, new methods12,13 for estimation of the variation
explained by GWA genotypes are applied to PGC-SCZ data14. We use only cases and
controls that are ‘unrelated’ in the classical sense and calculate the variance explained by
autosomal SNPs. The variance estimate is derived from the average genome-wide similarity
between all pairs of individuals determined using all SNPs. Genetic variation is estimated
when case-case pairs and control-control pairs are on average more similar genome-wide
than case-control pairs. We partition15 this genomic variation by chromosome, by sex, by
functional annotation and by minor allele frequency.
RESULTS
Genomic variation captured by common SNPs
The PGC-SCZ includes data from the International Schizophrenia Consortium (ISC)8, the
Molecular Genetics of Schizophrenia (MGS) study9 and other samples (OTH)
(Supplementary Table 1). Using a linear mixed model (Online Methods) we estimated the
proportion of variance in liability to schizophrenia explained by SNPs (h2) in each of these
three independent data subsets (Table 1). We use the notation h2 because the estimates
represent a lower bound of narrow sense heritability; it is a lower bound because only
variation due to association with the SNPs can be estimated. Preliminary analyses were
conducted using non-imputed genotypes of the ISC and MGS subsets (Supplementary Table
2). The estimates of h2 for the PGC-SCZ subsets of ISC, MGS and OTH were each greater
than the estimate from the total combined PGC-SCZ sample of h2 = 23% (s.e. 1%) (Table
1). We investigated this result by conducting bivariate analyses considering cases and
controls from one subset as trait 1 and those from a different subset as trait 2 (Table 2); the
two independent subsets are related through the coefficients of genome-wide similarity
calculated from SNPs between individuals (Online Methods equation 2). The estimated
correlation coefficients based on SNP genome-wide similarities are less than 1, consistent
with several explanations. Subsets may be more homogeneous both phenotypically, for
example because of similar and consistent diagnostic criteria, and genetically, because
linkage disequilibrium (LD) between causal variants and analysed SNPs may be higher
within than between subsets. Alternatively, subtle artefacts could generate non-random
differences in allele frequencies between sets of cases and sets of controls from the same
study. However, our preliminary analyses using genotyped SNPs for ISC and MGS and
extreme QC (Supplementary Table 2) suggest that this is unlikely to be a major contributor.
Furthermore, the correlations between data sets from the bivariate analyses are high (~0.8)
demonstrating that the same genetic signals can explain variance in schizophrenia liability in
different case-control samples collected; given that these samples were collected
independently with genotyping conducted at different laboratories, it is difficult to envision
artefacts that could generate such high correlations. Hence, we conclude that the PGC-SCZ
estimate of h2 represents the lower bound of variance in liability that would be explained by
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common SNPs in a large phenotypically and genetically homogeneous sample with no
genotyping artefacts.
Partitioning of genomic variation by chromosome
Cryptic population stratification has been proposed as a confounding factor in GWA
studies7. A consequence of population stratification is that segments of ancestry specific
chromosomes segregate together in the population. In this situation, variance attributed to
causal variants on one chromosome can be predicted by SNPs from segments derived from
the same ancestral population on other chromosomes. To investigate whether population
stratification could contribute to our results (over and above the ancestry principal
component scores included as covariates in the analyses), we performed two kinds of
analyses: one in which the similarity matrix for each chromosome was fitted separately (22
analyses estimating one additive genetic variance component per analysis) and a joint
analysis which fitted 22 similarity matrices simultaneously (estimating 22 additive genetic
variance components in a single analysis) (Online Methods). A higher total variance
explained by the 22 individually estimated variances compared to the 22 simultaneously
estimated variances would provide evidence of stratification. The total variance explained
was 26% for chromosomes fitted separately compared to a total of 23% when fitted together,
demonstrating little evidence of population stratification (Figure 1a). The estimates of
variance explained by each chromosome are linearly related with the length of the
chromosome (correlation = 0.89, p = 2.6 × 10−8), consistent with a highly polygenic model
and remarkably similar to results for human height12.
Genomic variation by sex
Sex differences have been described for almost all features of schizophrenia (prevalence,
incidence, age of onset, clinical presentation, course, response to treatment)16. To assess if
the variance in liability tagged by SNPs on autosomes differs between the sexes we
undertook a bivariate analysis considering male cases and controls as one trait and female
cases and controls as the other trait; the two independent subsets are related through the
coefficients of similarity calculated from SNPs (Online Methods equation 2). The
correlation in liabilities explained by SNPs between the sexes was very high (0.89 s.e. 0.06,
not significantly different from 1) (Table 2) implying that the majority of additive genetic
variance is shared between the sexes. We also investigated variance explained by genotyped
SNPs on the X chromosome for the ISC and MGS data sets and concluded that the variance
explained by the X chromosome is consistent with expectation given its length
(Supplementary Table 3).
Partitioning of genomic variation by functional annotation
To assess if functional annotation of SNPs is associated with the variance they explain we
partitioned the variance explained by SNPs into three components by creating similarity
matrices from SNPs in “CNS+” genes, other genes and no genes (Online Methods). The
CNS+ genes were the four sets identified by Raychaudhuri et al.28 and comprised the genes
in their brain-expressed (specifically, genes with differential CNS expression), neuronal
activity, learning and synapse sets. We find that the variance attributable to the CNS+ genes
is significantly greater than the proportion of the genome that they represent (31% s.e. 2% vs
20%, p = 7.6 × 10−8) (Figure 1b; Supplementary Table 4).
Partitioning of genomic variation by minor allele frequency of SNPs
It has been argued (e.g.6,7,18) that the low proportion of variance explained by previous
GWA studies of schizophrenia implies that common variants are unimportant to the etiology
of schizophrenia. To evaluate this hypothesis we undertook an analysis partitioning the
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variance tagged by SNPs into five components defined by minor allele frequency (MAF)
(Online Methods). For close relatives (who are excluded from our analyses), estimated
similarities based upon SNPs with different MAF will be similar. However, very distant
relatives inherit chromosome segments from distant common ancestors. If a SNP is more
recent than the common ancestor then the relationship between the individuals will not be
reflected by the SNP; low MAF SNPs tend to be younger than high MAF SNPs. The
variance explained by SNPs with MAF < 0.1 was 2% (s.e. 1%) from a joint analysis of all
five MAF bins in the total PGC-SCZ data (Supplementary Table 5, Figure 1c). This low
contribution to the total variance explained is likely to partly reflect under-representation of
SNPs with low MAF in the analysis (minimum MAF 0.01) relative to those in the genome.
The other four MAF bins explain approximately equal proportions of the variance, ~5% (s.e.
1%) each. Analyses of the PGC-SCZ subsets were consistent with these results
(Supplementary Table 5). Based on the known relationship between allele frequencies and
LD19, it is highly unlikely that the estimates of h2 reported here are caused predominantly by
rare causal variants20. We performed simulations conditional on PGC-SCZ data and
confirmed that a rare variants only model could not explain our results. For example, in an
analysis of PGC-SCZ data using only SNPs with MAF > 0.4, 11% (s.e. 1%) of the variance
in liability was explained, which is nearly half of the variance explained by all SNPs.
However, in simulations which attributed 50% of variation in liability to SNPs with MAF <
0.1, SNPs with MAF > 0.4 explained only 5% (s.e. 0.3%) of the variance, which is only
10% of the variation explained by all SNPs (Figure 1c,d; Supplementary Tables 5–6).
Furthermore, our simulation strategy is a best case scenario in favour of the rare variants
only model since our simulation extends the frequency of “rare” variants to MAF of 0.1
generating higher LD between the common genotyped SNPs and causal variants than would
be expected under a more usual MAF definition of “rare”. Our results are consistent with
analyses of the ISC data8,20. In the Supplementary Note we contrast our methods to the risk
profiling methods used by the ISC and the efficient mixed model association expedited
(EMMAX) method of Kang et al21.
DISCUSSION
We draw four important conclusions from these results. First, from direct queries of the
genome, we quantify the lower limit of the genetic contribution to schizophrenia;
approximately one quarter of the variance in liability is directly tagged by common variants
represented across the current generation of GWA arrays8 (Table 1) and this variance is
shared between the sexes (Table 2). Second, we provide evidence that causal risk variants
must include common variants (Figure 1d). Third, we provide evidence that the variance
explained by chromosomes is linearly related to the length of the chromosome (Figure 1b),
consistent with a highly polygenic model (many risk loci). Fourth, we find that the CNS+
gene set explains significantly (p = 7.6 × 10−8) more variation relative to the proportion of
the genome it represents. Together our results provide guidance for the future of genetic
studies in schizophrenia. Some have argued6,7,18 that common variants play little role in the
etiology of schizophrenia and that the GWA approach for schizophrenia has been
misconceived. Our results refute this conjecture that common variants play little role in the
etiology of schizophrenia and that the GWA approach for schizophrenia has been
misconceived by demonstrating that at least one quarter of variation in liability to
schizophrenia is tagged by SNPs and that common causal variants must be responsible for
most of this signal. Therefore, larger sample sizes are likely to achieve the statistical power
necessary to detect additional effects (over those detected to date) with genome-wide
significance. For example, a GWA for height17, considered as a model complex trait,
identified 180 robustly associated loci in a total sample size of 180,000 individuals and the
identified variants were concentrated in pathways biologically associated with growth.
Sample sizes of ~50,000 schizophrenia cases and 50,000 controls are needed to afford the
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same power to detect variants that explain the same proportion of phenotypic variance and
gain insight into biological pathways achieved in the height study11,12,22. Our results imply
that the GWA approach applied to larger case-control samples will deliver important results
for schizophrenia.
In conclusion, we estimate that about one quarter of variation in liability to schizophrenia, or
approximately one third of genetic variation in liability, is tagged when considering all
genotyped and imputed SNP simultaneously. The remaining ‘missing’ heritability most
likely reflects imperfect LD between causal variants and the genotyped and imputed SNPs.
The current generation of genotyping chips may explain only ~70% of the total variance
attributable to common SNPs (MAF > 0.1) and explains less of variance attributable to
uncommon and rare variants (Supplementary Figure 1). From the analyses we have
performed we cannot estimate a frequency distribution of the allele frequency of causal
variants, but the most likely cause of low LD between causal variants and SNPs is that many
causal variants have low MAF. Nevertheless, from the results presented we can conclude
that common causal variants in LD with genotyped and imputed SNPs must contribute to
genetic variation for liability to schizophrenia in the population. Hence, causal risk variants
for schizophrenia range across the entire “allelic spectrum”.
METHODS
See Online Methods for full details.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Genomic partitioning of schizophrenia. a) By chromosome: Estimated proportion of the
variance in liability to schizophrenia explained bySNPs on individual chromosomes from a
joint analysis of all chromosomes simultaneously or separate analyses for each chromosome
The sum of the h2 is 0.23 for the joint analysis and 0.26 for the separate analyses. b) By
annotation; the total variance explained by SNPs ( h2 ) in CNS+ genes, other genes and by
those not in genes totals 0.23. Of this, a proportion 0.31 is attributed to SNPs in brain genes,
which is greater than expected by chance (p = 7.6 × 10−8) given that the brain genes cover
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0.20 of the length of the genome (Mb) and represent 0.21 of the SNP count (N SNPs). Error
bars represent the 95% confidence intervals of the estimates. c) By MAF bin from analyses
fitting MAF bins jointly or each separately d) By MAF bin compared to simulation
under a rare variants only model. The variance explained by SNPs in each MAF bin
(when MAF bins are fitted in separate analyses) as a proportion of the variance explained by
all SNPs. Error bars represent 95% confidence intervals, for the simulations (right graph)
these are calculated using the standard deviation across simulation replicates.
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Table 1
Estimated proportion of variance in liability to schizophrenia explained by SNPs (h2).
Dataset Cases Controls h2 (SE)
ISC 3220 3445 0.27 (0.02)
MGS 2571 2419 0.31 (0.03)
OTH 3296 6307 0.27 (0.02)
ISC+MGS 5791 5864 0.25 (0.01)
PGC-SCZ 9087 12171 0.23 (0.01)
Estimates based on 915354 imputed SNPs; SE standard error of h2. PGC-SCZ is comprised of independent subsets ISC, MGS and OTH
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